Earnings announcements

ADT stockholders will receive $10.00 per share in cash, representing a 45.6% premium to ADT’s unaffected closing share price of $6.87 on October 27, 2026.The transaction brings together ADT’s security expertise, technology and nationwide network of professionals with Thrive Holdings’ long-term capital and engineering capabilities.Upon completion of the transaction, ADT will become a privately held company.Thrive Holdings’ permanent capital structure can support sustained investment in ADT’s products, technologies, capabilities and people over a long-term horizon.Thrive Holdings will uphold ADT’s longstanding commitment to protecting customer data, and ADT’s data protection and privacy polici

SALT LAKE CITY, Oct. 29, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its third quarter 2026 financial results on Thursday, November 12, 2026, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer and Daniel Bohrer, Executive Vice President of Finance and Accounting.

Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, Oct. 29, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced t that it will host a conference call on Thursday, November 5th, 2026 at 4:30pm EDT to discuss results for its quarter ended September 30, 2026 and to provide a corporate update.  Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Please ask for the INmune Bio Third Quarter Conference Call when reaching the operator. Date: November 5th, 2026 Time: 4:30

Thryv Holdings Inc. (NASDAQ:THRY) ("Thryv'' or the "Company"), provider of an AI-powered growth platform for local service businesses, today announced an updated date for its third quarter 2026 earnings release and conference call. The Company will now issue its earnings on November 9, 2026, after the market closes. The release will be followed by a conference call at 4:30 p.m. ET to discuss the results with the investment community.To listen to this conference call, please use this link or visit Thryv’s Investor Relations website at investor.thryv.com. A confirmation email with access details will be sent after registering. We recommend registering a day in advance or at minimum thirty minu

Board declares fourth quarter dividend on common and preferred stockSAN ANTONIO, Oct. 29, 2026 /PRNewswire/ -- Cullen/Frost Bankers, Inc. (NYSE:CFR) today reported third quarter 2026 results.Net income available to common shareholders for the third quarter of 2026 was $178.5 million, compared to $172.7 million for the third quarter of 2025. On a per-share basis, net income available to common shareholders for the third quarter of 2026 was $2.84 per diluted common share, compared to $2.67 per diluted common share reported a year earlier. Returns on average assets and average common equity were 1.31 percent and 16.16 percent, respectively, for the third quarter of 2026, compared to 1.32 percen

Madison Square Garden Entertainment Corp. (NYSE: MSGE) will host a conference call to discuss results for its fiscal first quarter ended September 30, 2026 on Wednesday, November 4, 2026 at 10:30 a.m. Eastern Time. The Company will issue a press release reporting its results prior to the market opening. To participate via telephone, please dial 833-461-5787 with the conference ID number 910557469 approximately 10 minutes prior to the call. The call will also be available via webcast at investor.msgentertainment.com under the heading "Events." For those who are unable to participate on the conference call, you may access a replay of the webcast on the website from 1:30 p.m. Eastern Time

Expected Fiscal Year Revenue of $60.5M to $62.0MExpected Fiscal Year Adjusted EBITDA of $7.2M to $8.2MEarnings Call Scheduled for December 15, 2026Genasys Inc. (NASDAQ:GNSS), the global leader in Protective Communications®, today announced preliminary unaudited financial results for its fiscal fourth quarter and fiscal year ended September 30, 2026. The Company also announced plans to release complete fiscal fourth quarter and full fiscal year 2026 financial results after the market close on Tuesday, December 15, 2026. A conference call to discuss the fiscal year financial results will be held on the same day at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.Preliminary Fiscal Fourth Quarte

ENGLEWOOD, Colo., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) today announced it will host a conference call at 4:30 p.m. ET Tuesday, November 10 to report its financial results for the third quarter ended September 30. To participate in the live call, please register through the following event weblink: https://registrations.events/direct/Q4I39798VIPxW5nsSJ16f5S3f To listen to the conference call (audio only, non-participating), please register through the following event weblink: https://events.q4inc.com/attendee/990337405 A webcast replay will be available after the conference call ends on November 10. The archived webcast will be available in the Investor Relations se

FAIRFAX, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- WidePoint Corporation (NYSE:WYY), a leading provider of Secure Mobility Management and Managed Services Solutions, will hold a conference call on Thursday, November 12, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2026. Financial results will be issued in a press release prior to the call. WidePoint’s management will host the conference call, followed by a question and answer period. Date: Thursday, November 12, 2026Time: 4:30 p.m. ET (1:30 p.m. PT) U.S. dial-in number: 888-506-0062International number: 973-528-0011Access Code: 633294 Please call the conference telephone number

MINNEAPOLIS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (NASDAQ:NSYS), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, aerospace & defense and industrial markets, will hold a live conference call and webcast at 3:30 p.m. Central Time on Thursday, November 12, 2026, to discuss the Company's third quarter 2026 financial results. The call will be hosted by Jay D. Miller, Chief Executive Officer and President, and Andrew D. C. LaFrence, Chief Financial Officer. To access the live audio conference call, US participants may call 888-506-0062 and international p

REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the third quarter of 2026 on Thursday, November 12, 2026, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update. Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-6

Conference Call to Discuss Results Scheduled for 10:00 a.m. ET TodayNEW YORK, Oct. 29, 2026 /PRNewswire/ -- Newmark Group, Inc. (NASDAQ:NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, today, reported its financial results for the three months ended September 30, 2026, and declared its quarterly dividend. A complete and full-text financial results press release, including information about today's financial results conference call and Newmark's dividend declaration, is accessible at either of t

CORSICANA, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Birchtech Corp. (NYSE:BCHT) (TSX:BCHT) ("Birchtech" or the "Company"), a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced that it will release financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 12, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time on Thursday, November 12, 2026, to discuss Birchtech's third quarter 2026 financial results and provide a corporate update. To participate, please use the following information: Third Quarter 2026 Earnings Conference CallDate: Thursday, November 12, 2

Buda Juice, Inc. (NYSE:BUDA, NYSE Texas: BUDA)) ("Buda Juice" or the "Company"), creator and pioneer of the Ultra Fresh™ category in the supermarket fresh produce department, today announced that it will release financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 12, 2026. Management will host an investor conference call at 4:30 p.m. Eastern time on Thursday, November 12, 2026 to discuss the Company’s third quarter 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information: Q3 2026 Earnings Conference Call Date: Thursday, November 12, 20

Conference Call and Webcast at 8:30 AM ETNEW YORK, Oct. 29, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it will host a business update conference call and webcast on Thursday, November 12, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's third quarter 2026 financial results.

GOOSE CREEK, S.C., Oct. 29, 2026 /PRNewswire/ -- HireQuest (NASDAQ:HQI), a national franchisor of on-demand staffing and direct-hire recruiting services, today announced that it will hold a conference call on Thursday, November 12, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2026. Date:Thursday, November 12, 2026Time:4:30 p.m. Eastern TimeToll-free dial-in number:888-506-0062International dial-in number:973-528-0011Entry code:327810Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.T

Veritone, Inc. (NASDAQ:VERI), a leader in enterprise AI and data solutions, today announced the details of its third quarter 2026 financial results conference call. Veritone will hold a conference call on Thursday, November 12, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time), to discuss its results for the third quarter 2026, provide an update on the business and conduct a question-and-answer session. To participate, please join the conference call or live audio webcast links or use the following dial-in numbers and ask to be connected to the Veritone earnings conference call. To avoid any delays, please join at least fifteen minutes prior to the start of the call. Conferenc

PLANTATION, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (NASDAQ:AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, will hold a conference call on Thursday, November 12, at 4:30 p.m. Eastern Time to discuss its results for the first quarter of fiscal year 2027 ended September 30, 2026. A press release detailing these results will be issued prior to the call. Alliance Entertainment Chief Executive Offic

SEATTLE, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Marchex, Inc. (NASDAQ:MCHX) ("Marchex" or the "Company"), a vertically focused, AI-driven conversation analytics, customer acquisition and optimization company, today announced that it will release financial results for the third quarter ended September 30, 2026, on Tuesday, November 10, 2026, after the close of the market. At that time, Marchex will post the press release in the Press Center section of its corporate website (https://www.marchex.com/about-us/press/).  Following the release, management will hold a conference call at 5:00 p.m. ET on Tuesday, November 10, 2026, to discuss the results and outlook for the company. A live webcast will

THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its third quarter 2026 financial results on Thursday, November 5, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.  Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique p

New license agreements drive Q3 results above guidance and increased FY26 outlookAnnualized recurring revenue1 at all-time high of $629 millionRevenue up 17% YoY; Net income up 19% YoY; Adjusted EBITDA2 up 25% YoY WILMINGTON, Del., Oct. 29, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a wireless, video, and AI technology research and development company, today announced results for the quarter ended September 30, 2026. "This was another excellent quarter, with double-digit growth in revenue and profitability and record annualized recurring revenue," said Liren Chen, President and CEO of InterDigital. "We secured a new PC license through arbitration and advanced our video se

MINNEAPOLIS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, today announced that it will release its financial results for the third quarter 2026 after the market closes on Thursday, November 5, 2026. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Standard Time to discuss the results and provide a corporate update. Webcast and Conference Call Information To participate in the teleconference, domestic callers should dial 1-800-717-1738 and international callers should dial 1-646-307-186

WEST DES MOINES, Iowa, Oct. 29, 2026 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (NASDAQ:WTBA, the "Company")), parent company of West Bank, today reported third quarter 2026 net income of $11.6 million, or $0.67 per diluted common share, compared to second quarter 2026 net income of $11.1 million, or $0.64 per diluted common share, and third quarter 2025 net income of $9.3 million, or $0.55 per diluted common share. On October 28, 2026, the Company’s Board of Directors declared a regular quarterly dividend of $0.26 per common share. The dividend is payable on November 25, 2026, to stockholders of record on November 11, 2026. David Nelson, President and Chief Executive Officer of the Co

Q3 2026 Financial Results and Business Update Conference Call and Webcast Scheduled for November 5, 2026 at 2:00 p.m. PT/5:00 p.m. ETALLO-329 Autoimmune Disease Program Webinar Featuring Preliminary Safety and Efficacy Data from the Phase 1 RESOLUTION Study Scheduled for November 9, 2026 at 6:00 a.m. PT/9:00 a.m. ETPreliminary Data from the Phase 1 RESOLUTION Trial will also be Presented at American College of Rheumatology (ACR) Convergence 2026 SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease,

MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that its third quarter 2026 financial results will be issued on the morning of Thursday, November 5, 2026. Management will host a conference call and webcast at 08:30 AM ET to discuss the results and provide business updates. To access the live conference call, participants may register here. Conference Details: Conference Date: Thursday, November 5, 2026Conference Time: 08:30 AM ETU.S. Dial-in: 1-877-704-4453International Dial-in:

FORT WORTH, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Yesway, Inc. ("Yesway" or the "Company") (NASDAQ:YSWY), one of the fastest-growing convenience store operators in the United States, today announced that it will issue its financial results for the third quarter ended September 30, 2026, before market open on Thursday, November 12, 2026. The Company will host a conference call and webcast to discuss the results that same day at 8:30 a.m. ET. Webcast DetailsA live webcast of the conference call will be available on the investor relations section of the Company’s website or by clicking on the webcast link here. An online archive of the webcast will be available on the Company’s website f

-  Return to Non-GAAP Profitability ahead of initial expectations - -  71% revenue growth backed by strong Design Win momentum -KFAR SAVA, Israel, Oct. 29, 2026 /PRNewswire/ -- Silicom Ltd. (NASDAQ:SILC), an industry-leading provider of high-performance server/appliance networking solutions, today reported its financial results for the third quarter ended September 30, 2026. Financial ResultsThird quarter: Silicom's revenues for the third quarter of 2026 reached $26.7 million, up 71% from $15.6 million for the third quarter of 2025.On a GAAP basis, the Company recorded a net loss of $0.3 million, or $0.06 per ordinary share (ba

Ameriprise Financial, Inc. (NYSE:AMP) today announced its third quarter 2026 results via an earnings release available on the company’s Investor Relations website at https://ir.ameriprise.com/financials/quarterly-results/. Management will host an investor conference call to review the results at approximately 9 a.m. (ET) today. Live audio of the conference call, presentation slides and an audio replay will be available on the company’s Investor Relations website at ir.ameriprise.com. At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 130 years. With extensive investment advice, global asset management capabilities and insurance

Intellinetics, Inc. ((INLX), a digital transformation solutions provider, today announced that it will report its financial results for the third quarter of 2026, the period ended September 30, 2026, on Thursday, November 12, 2026, after the close of the market. Management will discuss the results on a live webcast at 4:30 p.m. ET the same day. Interested parties can register for the webcast at https://intellinetics-third-quarter-2026-earnings-call.open-exchange.net, where a replay will also be available through February 10, 2027. About Intellinetics, Inc. Intellinetics, Inc. (NYSE:INLX) is a SaaS and document conversion services provider delivering secure, scalable automation and doc

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it will report its third quarter 2026 financial results after market close on Thursday, November 5, 2026. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and will be accessible from the Investor Relations section of the company

CORONA, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ:MNST) today announced that it will release its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026, after the market closes. The company also announced that Chief Executive Officer Hilton Schlosberg will host an investor conference call at 2:00 p.m. Pacific Time that day to discuss the company's financial performance and business operations. The call will be open to all interested investors through a live audio webcast via the Internet at www.monsterbevcorp.com. For those who are not able to listen to the live broadcast, the call will be archived for approxima

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ:FLNT), a leading provider of commerce media solutions, today announced that it will report its financial results for the quarter ended September 30, 2026, after the close of the U.S. financial markets on November 12, 2026. Fluent will host a conference call at 4:30 p.m. ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at Fluent Conference Call or via audio at Audio Registration. The call and accompanying slide presentation will also be webcast simultaneously on the Fluent website on the Investor Relations Page. Please log in at least 15 minutes prior to the star

Mastercard Incorporated (NYSE:MA) today announced its third quarter 2026 financial results through an earnings release available on the company’s Investor Relations website at investor.mastercard.com. The earnings release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K and available here. At 9:00 a.m. ET today, the company will host a conference call to discuss these financial results. Conference Call Details: North America Toll-free: +1 833 461 5787 International Toll: +1 585 542 9983 International Dial-Ins: https://help.events.q4inc.com/eahc/international-dial-in-numbers Meeting ID: 262177588 A replay of the call will be available for 30 days and c

GAITHERSBURG, Md., Oct. 29, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced that the Company plans to release its third quarter 2026 financial results before the open of the U.S. financial markets on Thursday, November 5, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights.Conference call details:Date:November 5, 2026Time: 8:30 a.m. ETURL to register phone:Register HereDial-in number:(+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International)Webcast:The live webcast can be accessed at ir.novavax.com/eventsParticipants can join the conference call witho

ELKHART, Ind., Oct. 29, 2026 /PRNewswire/ -- Patrick Industries, Inc. (NASDAQ:PATK) ("Patrick" or the "Company"), a leading component solutions provider for the Outdoor Enthusiast and Housing markets, today reported financial results for the third quarter and nine months ended September 27, 2026. Third Quarter 2026 Highlights (compared to Third Quarter 2025 unless otherwise noted)Net sales were $975 million compared to $976 million in the prior-year period. Strong revenue performance in Powersports (+30%) and Marine (+14%), along with Housing revenue growth of 4%, nearly offset a 15% decrease in RV revenue.Operating income was

TEL AVIV, Israel, Oct. 29, 2026 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ:ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that it will hold a conference call to discuss its third quarter 2026 financial results on Thursday, November 19, 2026 at 8:30 a.m. ET. The company will issue its financial results before the US market opens that same day. Conference Call and Webcast DetailsSpeakers will include Kobi Marenko, President, Ram Machness, Chief Executive Officer, and Assaf Pereg, Chief Financial Officer.The call will be webcast live and accessible from a link on Arbe's Investor Relations websit

DOWNERS GROVE, Ill., Oct. 29, 2026 /PRNewswire/ -- Federal Signal Corporation (NYSE:FSS) (the "Company"), a leader in environmental and safety solutions, today reported financial results for the third quarter ended September 30, 2026. Third Quarter HighlightsNet sales of $656 million, up $101 million, or 18%, from last yearOperating income of $111.4 million, up $17.4 million, or 19%, from last yearGAAP Diluted EPS of $1.29, up $0.18, or 16%, from last yearAdjusted EPS of $1.34, up $0.20, or 18%, from last yearOrders of $620 million, up $153 million, or 33%, from last yearOperating cash flow of $91 million, up $30 million, or 50%, from last yearRaises 2026 adjusted EPS* outlook to a new range

GARDEN CITY, N.Y., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended September 30, 2026 on Wednesday, November 11, 2026. The Company's management team is scheduled to host a conference call and webcast at 4:30 p.m. Eastern Time (ET) the same day. Conference Call & WebcastWednesday, November 11th @ 4:30 p.m. ETDomestic:                1-877-407-0784International:           1-201-689-8560Conference ID:        13763626Webca

MediWound to Report Third Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, November 12th at 8:30 a.m. Eastern Time YAVNE, Israel, October 29, 2026 -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the third quarter ended September 30, 2026, on Thursday, November 12, 2026. Following the release, Mediwound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update. Conference Call & Webcast Details Toll-Free:                1-844-676-8833Israel: 

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on Thursday, November 5, 2026, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT. Participants may access the live webcast of the conference call from the Events and Presentations page of CytomX’s website at https://ir.cytomx.com/events-and-presentations. Participants may register for the conference call here and are advised to do so at least 10 minutes prior t

ROCKAWAY, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial results for the third quarter ended September 30, 2026, after the market closes on Wednesday, November 4, 2026. Management will host a conference call and webcast at 4:30 PM EST that day to review the results and answer questions. Participants may join by telephone or webcast using the details below. Wednesday, November 4, 2026 at 4:30 pm ESTParticipant Dial-In: 877-407-8835 / +1 201-689-8779Conference ID #: 13763480Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=af6qsd3

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on November 5, 2026 at 4:30 pm ET (1:30 pm PT) to provide a business update and report third quarter 2026 financial results. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 90 d

Revenue Increases 33.9% to $72.0 Million, Driven by 119% U.S. Growth Achieves First Quarter of Positive Operating and Free Cash Flow and Raises Full-Year Revenue Guidance Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2026. Third Quarter Business Highlights Announced a new supply agreement with NuSil to support long-term manufacturing capacity and future growth. Received FDA approval for additional smaller Motiva implant sizes, expanding the range of options availa

Completed Previously Announced Transactions that Provided Approximately $680 Million in Asset Sale Proceeds and Significantly Extended Debt Maturities Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPT) today announced financial and operating results for the third quarter ended September 30, 2026, as well as certain events occurring subsequent to quarter end. Net income of $0.34 and Normalized Funds from Operations ("NFFO") of $0.11 for the 2026 third quarter, all on a per share basis; Completed the previously announced private offering of approximately $2.4 billion of secured notes, the proceeds of which were used to repay existing debt, including the 2026 notes as w

Third quarter net sales increased 7.7% year-over-year, driven by organic growth Third quarter operating profit increased to $11.5 million, while adjusted operating profit increased 47.9% to $13.6 million Third quarter diluted EPS increased to $0.37; adjusted diluted EPS increased to $0.50 Ended the quarter with $1.16 billion of cash and cash equivalents Signed agreement to sell flexible bag-in-box product line, further streamlining the portfolio and enhancing focus on core businesses TriMas (NASDAQ:TRS) today announced financial results for the third quarter ended September 30, 2026. TriMas reported third quarter 2026 net sales of $178.7 million, an increase of 7.7% compar

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will release results for its third quarter ended September 30, 2026, after the market closes on November 5, 2026. Natera will host a conference call and webcast shortly thereafter at 4:30 p.m. ET. Earnings Conference Call Information   Event: Natera’s Third Quarter 2026 Financial Results Date: November 5, 2026 Time: 4:30 p.m. ET Live Dial-In: 1-833-461-5787 (Domestic)   1-585-542-9983 (International) Conference ID: 221 556 643 Webcast: https://events.q4inc.com/atte

WALTHAM, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026, prior to the open of financial markets. Akebia will host a conference call on Thursday, November 5 at 8:00 a.m. EST to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial-in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.  A live webcast of the confere

− Generated Third Quarter 2026 Global Net Product Revenues of $1,292 Million (52% Growth Compared with Q3 2025), Driven Primarily by Total TTR Revenues of $1,150 Million (59% Growth Compared with Q3 2025) – − Expands Target Enrollment in TRITON-CM Phase 3 Study of Nucresiran to 2,250 Patients; Study Design Continues to Support Expected ATTR-CM Launch by 2030 – − Presented Positive Phase 1 Data for Brezosiran (ALN-HTT02) Demonstrating Robust Target Engagement and Encouraging Safety and Tolerability Profile in Patients with Huntington's Disease; Expect to Initiate Pivotal Study in 2027 – − On Track to Achieve 2026 Financial Guidance – Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the l

Insperity, Inc. (NYSE:NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the third quarter ended September 30, 2026. Insperity will be hosting a conference call today at 8:30 a.m. ET to discuss these results and our updated 2026 outlook and will be posting an accompanying presentation to our investor website at http://ir.insperity.com. Financial highlights for the quarter reflect the company’s margin recovery improvement as follows: Q3 revenues up 2% on a 2% decline in average paid WSEEs to 307,265 Q3 net loss improved 95% to $1 million; adjusted EBITDA up 210% to $31 million Q3 diluted EPS impr

Bankwell Financial Group, Inc. (NASDAQ:BWFG) reported GAAP net income of $12.7 million, or $1.58 per share for the third quarter of 2026, versus $12.4 million, or $1.52 per share, for the second quarter of 2026. The Company's Board of Directors declared a $0.20 per share cash dividend, payable November 20, 2026 to shareholders of record on November 9, 2026. The Company’s reported results include $3.0 million of non-interest expense attributed to core conversion costs incurred during the third quarter of 2026. For the third quarter of 2026, the Company reported GAAP net income of $12.7 million and operating net income(1) of $15.0 million. Operating results are non-GAAP financial measures t

EL MONTE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (NASDAQ:GCT) ("GigaCloud" or the "Company"), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that it will report financial results for the 2026 third quarter ended September 30, 2026 before the market opens on Thursday, November 5, 2026. The Company will host a conference call to discuss its financial results on the same day at 8:00 AM Eastern Time. To access the conference call, participants should pre-register here to receive the dial-in information and a unique PIN. All participants are encouraged to dial-in 15 minutes prior to the conference call’s start t

Company to report third quarter 2026 financial results on November 5 SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX:VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, today announced that members of the Company’s senior management team will participate in a virtual fireside chat on Friday, November 6, 2026, at 4:30 p.m. ET / 1:30 p.m. PT as part of its regular series to answer frequently asked questions from its stockholders. The Company plans to report financial results for the third quarter ended September 30, 2026, after the market close on Thursday, November 5, 20

York Space Systems Inc. (NYSE:YSS) will release its financial results for the quarter ended September 30, 2026 after the close of market on Thursday, November 12, 2026. In conjunction with this release, York will host a conference call to review its financial results for the quarter, discuss its outlook for the future and may disclose other material developments affecting its business and/or financial performance. Listeners may access the conference call live via an audio webcast. Thursday, November 12, 2026 3:00 pm Mountain Time (5:00 pm Eastern Time) Webcast: https://events.q4inc.com/attendee/739520037 York’s financial results release will be available after the close of market on Nov

Keysight Technologies, Inc. (NYSE:KEYS) will release financial results for the fourth quarter and fiscal year ending October 31, 2026, after the close of the stock market on Thursday, November 19, 2026. The company will host a conference call to discuss the results at 1:30 p.m. PT (4:30 p.m. ET) the same day. To join the audio webcast, click the link on the Upcoming Events section of the Keysight Investor Relations website, investor.keysight.com. A recording of the call will also be available on the website for 90 days in the News, Events, Presentations section. About Keysight Technologies Keysight (NYSE:KEYS) serves technology innovators as a mission-critical design enablement partne

NextDecade Corporation ("NextDecade," "we," or the "Company") (NASDAQ:NEXT) today provided an update on developmental and strategic activities for the third quarter of 2026. CEO Commentary "During the third quarter, we maintained strong momentum on Rio Grande LNG Phase 1 as we continued to advance construction and commissioning activities safely, on budget, and ahead of schedule," said Matt Schatzman, NextDecade Chairman and Chief Executive Officer. "The progress achieved to date continues to strengthen our confidence in our projected Phase 1 start-up timeline." "We expect first LNG production from Train 1 in the second quarter of 2027, and substantial completion of Train 1 in the thi

GREENWICH, Conn., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NASDAQ:OXLC) (NASDAQ:OXLCL) (NASDAQ:OXLCO) (NASDAQ:OXLCZ) (NASDAQ:OXLCN) (NASDAQ:OXLCI) (NASDAQ:OXLCG) (NASDAQ:OXLCM) announced today that it will hold a conference call to discuss its second fiscal quarter earnings on Thursday, November 5, 2026 at 9:00 AM ET. The toll-free dial-in number is 1-800-715-9871, access code number 3024474. There will be a recorded replay of the call available for 30 days after the call. If you are interested in hearing the recording, please dial 1-800-770-2030. The replay pass-code number is 3024474. About Oxford Lane Capital Corp. Oxford Lane Capital Corp. is a publicly-traded re

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ:NEXN) ("Nexxen" or the "Company"), the advertising technology platform powered by unique data and media, will release its financial results for the three and nine months ended September 30, 2026, before the U.S. market opens on Thursday, November 12, 2026. The Company will host a webcast and conference call at 9:00 AM ET on the same date to discuss its financial results and outlook. Webcast and Conference Call Details When: November 12, 2026, at 9:00 AM ETWebcast: A live and archived webcast can be accessed from the Events and Presentations section of Nexxen’s Investor Relations website at https://investors.ne

PETACH TIKVA, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that it will report its third quarter 2026 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 11, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minut

IRVINE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Shimmick Corporation ("Shimmick") (NASDAQ:SHIM), a national leader in complex infrastructure solutions, today announced that the company will release its third quarter 2026 financial results after market close on Thursday, November 12, 2026. Shimmick will also host a video webcast conference call to discuss those results at 4:30 p.m. Eastern Time on the same day. The conference call will be live-streamed via the Company’s Investor Relations website (https://investors.shimmick.com/). A copy of the earnings call presentation will also be posted to our website. A replay of the video webcast will be available through the same link following t

MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter financial results on Thursday, November 12, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. Parties interested in participating by phone should register using this online form. After registering for the webcast, dial-in details will be provided in an auto-generated e-mail containing a link to the conference phone number along with a personal pin. A live audio web